Dexamethasone and Block Duration in Upper Extremity

Duration of Pain Relief Clinical Trial

Official title:

A Study of the Effect of Dexamethasone on Duration of Upper Extremity Blocks With Bupivacaine

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT01756573
• Other study ID #: IRB12-2192
• Status: Terminated
• Phase: N/A
• Start date: January 2013
• Est. completion date: January 2015

Study information

• Verified date: April 2019
• Source: University of Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Effect of dexamethasone on prolonging upper extremity block is well known. But it not known if the effect comes from its local effect on the nerves or from its general analgesic effect. In this study we will compare the systemic effect to its local effect to find out if there is a difference or not.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 5
• Est. completion date: January 2015
• Est. primary completion date: January 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• age 18-75, no contraindication to regional anesthesia,

Exclusion Criteria:

• opioid user, chronic pain conditions, peripheral neuropathy

Related Conditions & MeSH terms

• Duration of Pain Relief

Intervention

Drug:
• Dexamthsone

• Bupivacaine

Locations

Country	Name	City	State
United States	University of Chicago Medical Center	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Analgesia Duration		72 hrs